Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Preissner

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
Inflammation|October 25, 2022
Betulin and Its Derivatives Reduce Inflammation and COX-2 Activity in MacrophagesWojciech Szlasa, Sylwester Ślusarczyk, Izabela Nawrot-Hadzik, et al.
Journal of Food Biochemistry|July 27, 2022
Underutilized legumes, Cajanus cajan and Glycine max may bring about antisickling effect in sickle cell disease by modulation of redox homeostasis in sickled erythrocytes and alteration of its functional chemistryGloria N Elemo, Ochuko L Erukainure, Jane N C Okafor, et al.
Bioorganic Chemistry|April 24, 2022
Non-psychotropic cannabinoids as inhibitors of TET1 proteinVeronika Antonyová, Zdeněk Kejík, Tereza Brogyanyi, et al.
BMC Psychiatry|October 7, 2025
The role of 5-hydroxytryptamine receptor 2A (HTR2A) gene polymorphisms in treatment-resistant obsessive-compulsive disorder: a comparative study with other treatment-resistant mental disordersAntonio Del Casale, Giovanna Gentile, Jan Francesco Arena, et al.
Plos Biology|June 2, 2017
Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1Manisha Juneja, Dennis Kobelt, Wolfgang Walther, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 11, 2025
Investigating DRD2 and HTR2A polymorphisms in treatment-resistant schizophrenia: a comparative analysis with other treatment-resistant mental disorders and the healthy stateAntonio Del Casale, Giovanna Gentile, Simone Lardani, et al.
International Journal of Cancer|March 18, 2009
Survivin minigene DNA vaccination is effective against neuroblastomaStefan Fest, Nicole Huebener, Matthias Bleeke, et al.
Journal of Personalized Medicine|February 25, 2022
Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up StudyAntonio Del Casale, Leda Marina Pomes, Luca Bonanni, et al.
Pigment Cell & Melanoma Research|June 1, 2025
Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World StudySilvia Mezi, Andrea Botticelli, Giulia Pomati, et al.
Cancers|September 28, 2023
The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic MelanomaSilvia Mezi, Andrea Botticelli, Simone Scagnoli, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Inflammation|October 25, 2022
Betulin and Its Derivatives Reduce Inflammation and COX-2 Activity in MacrophagesWojciech Szlasa, Sylwester Ślusarczyk, Izabela Nawrot-Hadzik, et al.
Journal of Food Biochemistry|July 27, 2022
Underutilized legumes, Cajanus cajan and Glycine max may bring about antisickling effect in sickle cell disease by modulation of redox homeostasis in sickled erythrocytes and alteration of its functional chemistryGloria N Elemo, Ochuko L Erukainure, Jane N C Okafor, et al.
Bioorganic Chemistry|April 24, 2022
Non-psychotropic cannabinoids as inhibitors of TET1 proteinVeronika Antonyová, Zdeněk Kejík, Tereza Brogyanyi, et al.
BMC Psychiatry|October 7, 2025
The role of 5-hydroxytryptamine receptor 2A (HTR2A) gene polymorphisms in treatment-resistant obsessive-compulsive disorder: a comparative study with other treatment-resistant mental disordersAntonio Del Casale, Giovanna Gentile, Jan Francesco Arena, et al.
Plos Biology|June 2, 2017
Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1Manisha Juneja, Dennis Kobelt, Wolfgang Walther, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 11, 2025
Investigating DRD2 and HTR2A polymorphisms in treatment-resistant schizophrenia: a comparative analysis with other treatment-resistant mental disorders and the healthy stateAntonio Del Casale, Giovanna Gentile, Simone Lardani, et al.
International Journal of Cancer|March 18, 2009
Survivin minigene DNA vaccination is effective against neuroblastomaStefan Fest, Nicole Huebener, Matthias Bleeke, et al.
Journal of Personalized Medicine|February 25, 2022
Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up StudyAntonio Del Casale, Leda Marina Pomes, Luca Bonanni, et al.
Pigment Cell & Melanoma Research|June 1, 2025
Impact of Drug-Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real-World StudySilvia Mezi, Andrea Botticelli, Giulia Pomati, et al.
Cancers|September 28, 2023
The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic MelanomaSilvia Mezi, Andrea Botticelli, Simone Scagnoli, et al.
Pageof 20